Abstract
Coronavirus disease 2019 (COVID-19) characterized by immuno-pathological host responses including pneumonia, lymphopenia, and cytokine storm that leads to severe lung inflammation, developed in acute respiratory distress syndrome (ARDS). In the absence of an effective vaccine or any definitive cure, the use of host-directed therapies is an effective alternative and demanding treatment option in the current pandemic outbreak of COVID-19.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1117-1120 |
| Number of pages | 4 |
| Journal | Expert Opinion on Biological Therapy |
| Volume | 20 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2 2020 |
Keywords
- Covid-19
- host-directed
- Infectious disease
- SARS-CoV-2
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
- Clinical Biochemistry
Fingerprint
Dive into the research topics of 'Host-directed therapies: a potential solution to combat COVID-19'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS